Clinical Trial

An At-distance and Online Intervention to Promote Parental Involvement and Self-regulation

Study acronym: Lupis
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Parents play a significant role in their children's development and learning. Parental involvement (PI) is characterized by behavioral profiles that are manifested in activities at home (e.g., helping with homework) and school (e.g., participating in meetings with teachers). Involved parents tend to create more opportunities for their children to develop different competencies. These competencies are relevant to children's academic success, namely, the knowledge and use of self-regulation (SR) strategies. SR strategies enable children to take control and responsibility for their behaviors, thoughts, and emotions, thereby achieving a goal (e.g., an academic goal), which in turn leads to higher academic performance and well-being. Extensive research has identified PI and SR as strong predictors of children's academic success, underscoring the need to promote them actively. Thus, the main goal of this investigation - the Lupis program - is to develop and evaluate the efficacy of an at-distance and online intervention program for parents of 1st and 2nd grade elementary school students. The Lupis will be a narrative-based intervention, utilizing wise intervention techniques in its design. The Lupis program will aim to promote PI and, consequently, SR competencies in children. In general, it is expected to develop an effective intervention program to promote PI and SR competencies in children. Additionally, Lupis is expected to help parents and children prevent and address the challenges of transitioning from preschool to elementary school with essential competencies for children's learning and academic success.
Trial Details
NCT Number NCT07400978
Lead Sponsor University of Minho
Collaborators: Foundation for Science and Technology, Portugal
Conditions Parental Involvement, Self-regulation in Children
Enrollment 150 participants
Start Date 2024-10-07
Primary Completion 2025-06-30 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10